In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides

By Moss R.B.   Diveley J.   Jensen F.   Carlo D.J.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1081-1087

Elsevier

Access to resources Recommend Favorite

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

By Barnett S.W.   Rajasekar S.   Legg H.   Doe B.   Fuller D.H.   Haynes J.R.   Walker C.M.   Steimer K.S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 869-873

Elsevier

Access to resources Recommend Favorite

Generation of Th1 immune responses to inactivated, gp120-depleted HIV-1 in mice with a dominant Th2 biased immune profile via imunostimulatory oligonucleotides-relevance to AIDS vaccines in developing countries

By Ayash-Rashkovsky M.   Weisman Z.   Diveley J.   Moss R.B.   Bentwich Z.   Borkow G.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2684-2692

Elsevier

Access to resources Recommend Favorite

Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial

By Ugen K.E.   Boyer J.D.   Wang B.   Bagarazzi M.   Javadian A.   Frost P.   Merva M.M.   Agadjanyan M.G.   Nyland S.   Williams W.V.   Coney L.   Ciccarelli R.   Weiner D.B.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 927-930

Elsevier

Access to resources Recommend Favorite

Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120

By Pinter A.   Honnen W.J.   Kayman S.C.   Trochev O.   Wu Z.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1803-1811

Elsevier

Access to resources Recommend Favorite